Alembic Pharmaceuticals reports 45% fall in Q1 consolidated net profit

26 Jul 2021 Evaluate

Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2021.

The company has reported a fall of 39.53% in its net profit at Rs 192.69 crore for the quarter under review as compared to net profit of Rs 318.64 crore for the same quarter in the previous year. However, total income of the company decreased by 1.02% at Rs 1271.43 crore for Q1FY22 as compared Rs 1258.59 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 45.43% in its net profit after taxes, non-controlling interests and share of profit of Associates and Joint Ventures at Rs 164.52 crore for the quarter under review as compared to net profit of Rs 301.46 crore for the same quarter in the previous year. Total income of the company marginally increased by 1.02% at Rs 1327.91 crore for Q1FY22 as compared Rs 1341.64 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

843.15 -9.15 (-1.07%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×